Newly Approved Drug a ' Revolution ' for Postpartum Depression Newly Approved Drug a ' Revolution ' for Postpartum Depression

The marked improvement in postpartum depression within 60 hours of intravenous brexanolone infusion is sustained over 30 days, with half of patients still responding, a pooled analysis of three RCTs shows.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Psychiatry News Source Type: news